Received Mar 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | LP1780 | LA |
Olfactory issue. Breathing in odor/having a smelling issue. When patient breathe in with nose, patient smell something different and there is no outside influences. Right it is olfactory issues; This is a spontaneous report and received from Consumer or other non HCPs. A 73-year-old male patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 28Feb2025 at 15:00 as dose 1, single (Lot number: LP1780) at the age of 73 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypersensitivity" (unspecified if ongoing). There were no concomitant medications. The following information was reported: PAROSMIA (non-serious) with onset 28Feb2025 at 16:00, outcome "not recovered", described as "Olfactory issue. Breathing in odor/having a smelling issue. When patient breathe in with nose, patient smell something different and there is no outside influences. Right it is olfactory issues". Therapeutic measures were not taken as a result of parosmia. Additional information: Facility vaccine was administered from pharmacy or drug store. Patient was not receive any other vaccines within 4 weeks PRIOR to the vaccine. Patient was not taking any other medications within 2 weeks of the event starting. Reported Event Olfactory issue. Breathing in I notice an odor. Patient stated, having a smelling issue. When patient breathe in with nose, patient smell something different and there is no outside influences. Right, it is olfactory issues, smelling.
Medical History/Concurrent Conditions: Hypersensitivity